Kazazian Asset Management, LLC - Q2 2017 holdings

$66.1 Million is the total value of Kazazian Asset Management, LLC's 52 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was 50.0% .

 Value Shares↓ Weighting
EEM NewISHARES TRmsci emg mkt etf$8,071,000195,000
+100.0%
12.22%
SPY SellSPDR S&P 500 ETF TRtr unit$7,533,000
-72.9%
31,154
-73.6%
11.40%
-70.4%
CLNS BuyCOLONY NORTHSTAR INC$6,218,000
+16.6%
441,271
+6.9%
9.41%
+27.5%
GM BuyGENERAL MTRS CO$6,190,000
+7.9%
177,204
+9.2%
9.37%
+18.0%
GOOG  ALPHABET INCcap stk cl c$3,482,000
+9.5%
3,8320.0%5.27%
+19.7%
C  CITIGROUP INC$3,373,000
+11.8%
50,4310.0%5.11%
+22.2%
RESI  ALTISOURCE RESIDENTIAL CORPcl b$2,781,000
-15.2%
214,9250.0%4.21%
-7.2%
AAPL  APPLE INC$2,170,000
+0.2%
15,0700.0%3.28%
+9.6%
SLV  ISHARES SILVER TRUSTishares$2,157,000
-8.9%
137,3000.0%3.26%
-0.4%
EWG NewISHARESmsci germany etf$1,665,00055,000
+100.0%
2.52%
BIIB SellBIOGEN INC$1,628,000
-41.6%
6,001
-41.2%
2.46%
-36.2%
VRX  VALEANT PHARMACEUTICALS INTL$1,337,000
+56.7%
77,3110.0%2.02%
+71.4%
BABA  ALIBABA GROUP HLDG LTDsponsored ads$1,192,000
+30.7%
8,4600.0%1.80%
+42.8%
BPMC NewBLUEPRINT MEDICINES CORP$1,179,00023,273
+100.0%
1.78%
BIDU  BAIDU INCspon adr rep a$1,114,000
+3.6%
6,2290.0%1.69%
+13.2%
CLVS NewCLOVIS ONCOLOGY INC$1,055,00011,264
+100.0%
1.60%
GDX BuyVANECK VECTORS ETF TRgold miners etf$969,000
+27.3%
43,881
+31.5%
1.47%
+39.2%
IAC  IAC INTERACTIVECORP$965,000
+40.1%
9,3510.0%1.46%
+53.1%
EWZ NewISHARESmsci brz cap etf$888,00026,000
+100.0%
1.34%
BMY BuyBRISTOL MYERS SQUIBB CO$847,000
+41.2%
15,207
+37.9%
1.28%
+54.3%
ALXN BuyALEXION PHARMACEUTICALS INC$818,000
+72.9%
6,723
+72.4%
1.24%
+89.0%
PMT SellPENNYMAC MTG INVT TR$769,000
-48.5%
42,045
-50.0%
1.16%
-43.7%
MU  MICRON TECHNOLOGY INC$747,000
+3.3%
25,0000.0%1.13%
+13.0%
AAMC  ALTISOURCE ASSET MGMT CORP$530,000
+21.6%
5,8000.0%0.80%
+32.8%
PRGO  PERRIGO CO PLC$529,000
+13.8%
7,0000.0%0.80%
+24.4%
ABT  ABBOTT LABS$520,000
+9.5%
10,6880.0%0.79%
+19.6%
SALT BuySCORPIO BULKERS INC$513,000
-7.6%
72,315
+19.9%
0.78%
+1.0%
GREK NewGLOBAL X FDSmsci greece etf$506,00050,000
+100.0%
0.77%
AERI NewAERIE PHARMACEUTICALS INC$450,0008,558
+100.0%
0.68%
MRK NewMERCK & CO INC$439,0006,848
+100.0%
0.66%
JUNO NewJUNO THERAPEUTICS INC$428,00014,307
+100.0%
0.65%
AUPH BuyAURINIA PHARMACEUTICALS INC$406,000
+23.0%
66,304
+47.3%
0.62%
+34.6%
UA BuyUNDER ARMOUR INCcl c$403,000
+46.5%
20,000
+33.3%
0.61%
+60.1%
SGEN NewSEATTLE GENETICS INC$354,0006,848
+100.0%
0.54%
AZN SellASTRAZENECA PLCsponsored adr$350,000
-8.4%
10,271
-16.4%
0.53%
+0.2%
UCP SellUCP INCcl a$343,000
-11.8%
31,291
-18.4%
0.52%
-3.7%
GDXJ SellVANECK VECTORS ETF TRjr gold miners e$334,000
-52.4%
10,000
-48.7%
0.51%
-47.9%
EIGI NewENDURANCE INTL GROUP HLDGS I$316,00037,847
+100.0%
0.48%
BMRN NewBIOMARIN PHARMACEUTICAL INC$311,0003,424
+100.0%
0.47%
SNH  SENIOR HSG PPTYS TRsh ben int$304,000
+1.0%
14,8770.0%0.46%
+10.3%
GSK NewGLAXOSMITHKLINE PLCsponsored adr$295,0006,850
+100.0%
0.45%
GMWSB  GENERAL MTRS CO*w exp 07/10/201$292,000
-2.7%
16,8140.0%0.44%
+6.5%
BLUE SellBLUEBIRD BIO INC$252,000
-10.6%
2,396
-22.7%
0.38%
-2.6%
PICO SellPICO HLDGS INC$231,000
+22.2%
13,196
-2.3%
0.35%
+33.6%
RARE NewULTRAGENYX PHARMACEUTICAL IN$213,0003,424
+100.0%
0.32%
PBYI NewPUMA BIOTECHNOLOGY INC$209,0002,393
+100.0%
0.32%
GTE  GRAN TIERRA ENERGY INC$103,000
-14.9%
45,9360.0%0.16%
-7.1%
SAN  BANCO SANTANDER SAadr$100,000
+9.9%
15,0000.0%0.15%
+19.8%
CLF  CLIFFS NAT RES INC$84,000
-15.2%
12,1140.0%0.13%
-7.3%
MTLPR  MECHEL PAOspon adr pfd$47,000
+2.2%
44,2980.0%0.07%
+10.9%
EQS SellEQUUS TOTAL RETURN INC$45,000
-10.0%
19,073
-4.5%
0.07%
-1.4%
GMOLQ  GENERAL MOLY INC$8,000
-20.0%
20,8950.0%0.01%
-14.3%
LEJU ExitLEJU HLDGS LTDsponsored ads$0-9,225
-100.0%
-0.04%
TWTR ExitTWITTER INC$0-16,300
-100.0%
-0.34%
PAH ExitPLATFORM SPECIALTY PRODS COR$0-19,293
-100.0%
-0.35%
BIVV ExitBIOVERATIV INC$0-5,598
-100.0%
-0.42%
MTG ExitMGIC INVT CORP WIS$0-37,565
-100.0%
-0.53%
HEWG ExitISHARES TRhdg msci germn$0-38,542
-100.0%
-1.49%
MITT ExitAG MTG INVT TR INC$0-67,147
-100.0%
-1.68%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2017-08-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
GENERAL MTRS CO20Q3 20199.4%
APPLE INC20Q3 20198.8%
CITIGROUP INC20Q3 20196.2%
ALIBABA GROUP HLDG LTD20Q3 20192.6%
EQUUS TOTAL RETURN INC20Q3 20190.1%
MECHEL PAO20Q3 20190.1%
GENERAL MOLY INC20Q3 20190.0%
GENERAL MTRS CO19Q2 20190.5%
SPDR S&P 500 ETF TR17Q3 201951.5%
BAIDU INC17Q3 20196.5%

View Kazazian Asset Management, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
Kazazian Asset Management, LLC Q2 2017 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
GEE Group Inc.February 14, 2022182,5550.2%
Bonds.com Group, Inc.July 10, 201328,57110.5%

View Kazazian Asset Management, LLC's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G/A2022-02-14
SC 13G2021-04-29
13F-HR2019-11-14
13F-HR2019-08-14
13F-HR2019-05-15
13F-HR2019-02-14
13F-HR2018-11-14
13F-HR2018-08-14
13F-HR2018-05-15
13F-HR2018-02-15

View Kazazian Asset Management, LLC's complete filings history.

Compare quarters

Export Kazazian Asset Management, LLC's holdings